top of page
Teladoc Health and Livongo Merger
By: AJ Tomas (University of Chicago), Demi Akinjide, Saihejpal Ailwadhi, Ben Fobel, Zac Greenberg (University of Bristol) Overview of the...
The MergerSight Group
Sep 5, 202010 min read
Mylan’s Merger with Pfizer’s Upjohn Unit
Pfizer’s UpJohn franchise is merging with Mylan- the troubled EpiPen manufacturer shrouded in price fixing controversies.
mergersight
Sep 7, 20197 min read
AbbVie’s $63 billion Acquisition of Allergan
US drugmaker AbbVie launched a $63 billion bid for Botox maker Allergan in what will result in the world’s fifth largest drug company.
mergersight
Jul 27, 20197 min read
Danaher $21.4bn acquisition of General Electric’s Life Sciences division
General Electric sold its Life Sciences division to Danaher Corporation for $21.4bn, as part of GE's plan to push further its aviation.
mergersight
Jun 15, 20195 min read
Roche’s $4.3 billion acquisition of Spark
Roche, the Swiss drugs group, has won a two-way race to acquire Spark Therapeutics, Inc. for $4.8bn.
The MergerSight Group
May 8, 20194 min read
Merck’s $2.4bn acquisition of Antelliq
Merck's strategic acquisition of Antelliq leads the path to sustainable and significant investments in agricultural technologies.
The MergerSight Group
Mar 13, 20194 min read
Eli Lilly’s $8bn Acquisition of Loxo Oncology
Eli Lilly’s most recent acquisition marks a clear strategic path towards immunotherapy and oncology for the firm.
The MergerSight Group
Mar 9, 20195 min read
Johnson and Johnson’s $3.4bn acquisition of Auris Health
Amidst a pharma spending spree, Johnson & Johnson $3.4bn acquisition of Auris Health is a move towards turning around its medical devices.
mergersight
Mar 2, 20195 min read
Cigna’s $70bn acquisition of Express Scripts Holding Co.
Cigna’s $70bn acquisition of Express Scripts was the biggest deal by volume announced in 2018, but was it the smartest?
The MergerSight Group
Feb 13, 20196 min read
Bristol-Myers Squibb’s $74bn Acquisition of Celgene
This deal will allow the biopharmaceutical giant to diversify its drug portfolio and stay on the cutting edge of experimental therapy.
The MergerSight Group
Jan 26, 20195 min read
LifePoint Health’s $5.6 bn Merger with RCCH HealthCare Partners
By Carlos Asorey (Georgetown University) 26/10/2018 | Overview of the deal Acquirer: RCCH HealthCare Partners Target: LifePoint Health...
mergersight
Oct 26, 20184 min read
Takeda’s $62 billion Acquisition of Shire
Overview of the deal Acquirer: Takeda Target: Shire Estimated value: $62 bn Announcement date: 08/05/18 Takeda Advisors: Evercore, JP...
mergersight
Jun 18, 20185 min read
Bayer’s $66 billion Acquisition of Monsanto
Overview of the deal Acquirer: Bayer Target: Monsanto Estimated value: $66 billion Announcement date: May 2016 Acquirer Advisors: Credit...
mergersight
Mar 26, 20184 min read
Sanofi’s proposed $11.6 billion Acquisition of Bioverativ
Overview of the deal Acquirer: Sanofi SA (Paris: SAN) Target: Bioverativ. (NASDAQ: BIVV) Estimated value: $11.6bn Announcement date: 3/12...
mergersight
Mar 12, 20185 min read
Luxottica and Essilor agree $54bn merger
Overview of the deal Initiating firm: Essilor Approached firm: Luxottica Estimated value: $54 Bn (including net debt) Announcement:...
mergersight
Feb 27, 20184 min read
CVS Health’s $77 billion acquisition of Aetna
Overview of the deal Acquirer: CVS Health Corporation (NYSE: CVS) Target: Aetna Inc. (NYSE: AET) Estimated value: $69bn ($77bn including...
mergersight
Feb 15, 20184 min read
bottom of page